1. World Health Organization Regional Office for Africa. Substance Abuse. Geneva: World Health Organization; 2023.
2. United Nations Office on Drugs and Crime. World Drug Report 2020: Drug Use and Health Consequences. Vienna: United Nations Office on Drugs and Crime; 2020.
3. Rostam-Abadi Y, Gholami J, Jobehdar MM, et al. Drug use, drug use disorders, and treatment services in the Eastern Mediterranean region: a systematic review. Lancet Psychiatry. 2023;10:282-95.
4. Moradinazar M, Najafi F, Jalilian F, et al. Prevalence of drug use, alcohol consumption, cigarette smoking and measure of socioeconomic-related inequalities of drug use among Iranian people: findings from a national survey. Substance Abuse Treatment Prevention and Policy. 2020;15:39.
5. Masoumi Z, Shayan A, Azizi S, et al. Incidence of complications among infants born from addicted mothers in Fatemieh hospital in Shahroud City, Iran. Journal of Biostatistics and Epidemiology. 2018;4:24-9.
6. Tabatabaei SM, Behmanesh-Pour F, Salimi-Khorashad A, et al. Substance use and its associated factors among pregnant women: a cross-sectional study in the southeast of Iran. Addiction and Health. 2018;10:162-72.
7. Fuchs JR, Schiff MA, Coronado E. Substance Use Disorder-Related Deaths and Maternal Mortality in New Mexico, 2015–2019. Maternal and Child Health Journal. 2023;27:23-33.
8. Keller JM, A-Hammadi N, Bass S, et al. Substance Use Disorder and Severe Maternal Morbidity: Is there a Differential Impact? American Journal of Obstetrics & Gynecology MFM. 2025;7:101544.
9. Shirzad AA, Jalili E, Shahbazi F, et al. Epidemiological and Maternal Features of Maternal Mortality in the West of Iran: Hamadan, 2011-2019. Current Women’s Health Reviews. 2022;18:87-91.
10. Ragsdale AS, Al-Hammadi N, Loux TM, et al. Perinatal substance use disorder: Examining the impact on adverse pregnancy outcomes. European Journal of Obstetrics & Gynecology and Reproductive Biology: X. 2024;22:100308.
11. Cortez Ferreira M, Moura Figueiredo A, Pitorra J, et al. Impact of a qualitative assessment approach for neonatal abstinence syndrome management: experience of a European reference center. Italian Journal of Pediatrics. 2024;50:224.
12. Figeys C. Clinical practice guidelines for the management of neonatal abstinence syndrome: A systematic review and evaluation. [Thesis]. Ottawa: University of Ottawa; 2023.
13. Plouffe R, Grywacheski V, Luo W, et al. Neonatal abstinence syndrome hospitalizations in Canada: a descriptive study. Canadian Journal of Public Health. 2023;114:277-86.
14. Lisonkova S, Wen Q, Richter LL, et al. Neonatal abstinence syndrome and infant mortality and morbidity: a population-based study. Frontiers in Pediatrics. 2024;12:1394682.
15. Bagheri F, Ramezani M, Boskabadi H, et al. Challenges of Infant Care in Mothers With Substance Use: A Qualitative Research in Iran. International Journal of Women’s Health and Reproduction Science. 2025;13:3-12.
16. Burduli E, Jones HE. Beyond a simple cause and effect relationship: Exploring the long-term outcomes of children prenatally exposed to opioids and other substances. Seminars in Perinatology. 2025;49:152010.
17. Parolin M, Simonelli A. Attachment theory and maternal drug addiction: The contribution to parenting interventions. Frontiers in Psychiatry. 2016;7:152.
18. Lara IB, Horsch A, Hilfiker R, et al. Maternal risk factors for infant foster care from birth: A retrospective observational study. Child Protection and Practice. 2025;4:100095.
19. Rockefeller K, Macken LC, Craig A. Trying to do what is best: a qualitative study of maternal–infant bonding and neonatal abstinence syndrome. Advances in Neonatal Care. 2019;19:E3-15.
20. Bigalky J. Who cares for the mothers?: A narrative inquiry exploring substance use disorders among pregnant women. International Health Trends and Perspectives. 2023;3:216-25.
21. Jansson LM, Velez M. Neonatal abstinence syndrome. Current Opinion in Pediatrics. 2012;24:252-8.
22. Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qualitative Health Research. 2005;15:1277-88.
23. Lindgren BM, Lundman B, Graneheim UH. Abstraction and interpretation during the qualitative content analysis process. International Journal of Nursing Studies. 2020;108:103632.
24. Guba EG, Lincoln YS. Competing paradigms in qualitative research. In: Denzin NK, Lincoln YS, editors. Handbook of Qualitative Research. Thousand Oaks: Sage Publications; 1994. p. 105-17.
25. Canfield M, Radcliffe P, Marlow S, et al. Maternal substance use and child protection: a rapid evidence assessment of factors associated with loss of child care. Child Abuse and Neglect. 2017;70:11-27.
26. Villegas NA, Chodhury SM, Mitrani VB, et al. Mothers in substance abuse recovery: Perspectives on motivators, challenges and family involvement. International Journal of High Risk Behaviors and Addiction. 2016;6:e32558.
27. Adams ZM, Ginapp CM, Price CR, et al. “A good mother”: Impact of motherhood identity on women’s substance use and engagement in treatment across the lifespan. Journal of Substance Abuse Treatment. 2021;130:108474.
28. Chou JL, Cooper-Sadlo S, Diamond RM, et al. An exploration of mothers’ successful completion of family-centered residential substance use treatment. Family Process. 2020;59:1113-27.
29. Nord-Baade S, Ness O, Jensen CB, et al. Barriers and facilitators for social inclusion among people with concurrent mental health and substance use problems: A qualitative scoping review. PLoS One. 2024;19:e0315758.
30. Adeniran E, Quinn M, Wallace R, et al. A scoping review of barriers and facilitators to the integration of substance use treatment services into US mainstream health care. Drug and Alcohole Dependence Reports. 2023;7:100152.
31. Bagheri F, Ramezani M, Boskabadi H, et al. Drug-Dependent Mother’s Needs in Childcare: An Integrative Literature Review. Crescent Journal of Medical and Biological Sciences. 2025;12:3-12.
32. Brakenhoff B, Slesnick N. “The whole family suffered, so the whole family needs to recover”: Thematic analysis of substance-abusing mothers’ family therapy sessions. Journal of Social Service Research. 2015;41:216-32.
33. Raitasalo K, Holmila M. Parental substance abuse and risks to children’s safety, health and psychological development. Drugs Education Prevention and Policy. 2017;24:17-22.
34. Jääskeläinen M, Holmila M, Notkola IL, et al. Mental disorders and harmful substance use in children of substance abusing parents: a longitudinal register-based study on a complete birth cohort born in 1991. Drug and Alcohol Review. 2016;35:728-40.
35. Couvrette A, Brochu S, Plourde C. The “Deviant Good Mother”: Motherhood experiences of substance-using and lawbreaking women. Journal of Drug Issues. 2016;46:292-307.
36. Meulewaeter F, De Pauw SSW, Vanderplasschen W. Mothering, substance use disorders and intergenerational trauma transmission: An attachment-based perspective. Frontiers in Psychiatry. 2019;10:728.
37. Saunt JV, Montoya CN. Pregnant and parenting women with substance use disorders and the child welfare system in the United States of America: a scoping review. Journal of Public Health. 2025. [online]
38. Lewis QJ, Smith BD, Offiong A, et al. When a house is never a home: Housing instability among youth affected by parental drug abuse. Child Abuse and Neglect. 2021;118:105131.
39. Compton WM, Wargo EM, Volkow ND. Neuropsychiatric Model of Addiction Simplified. Psychiatric Clinic of North America. 2022;45:321-34.
40. Raynor P, Corbett C, Prinz R, et al. Using community-based participatory methods to design a digital intervention for mothers with substance use disorders: Qualitative results from focus group discussions. Perspectives in Psychiatric Care. 2022;58:615-22.
41. Barrett S, Muir C, Burns S, et al. Interventions to reduce parental substance use, domestic violence and mental health problems, and their impacts upon children’s well-being: A systematic review of reviews and evidence mapping. Trauma Violence and Abuse. 2024;25:393-412.